Wyeth Presents Data On A Tissue Selective Estrogen Complex Class For Menopausal Therapy
Thu, 02 Nov 2006 08:00 AM EST
... Today, Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), presented Phase 2 clinical data at the American Society for Reproductive Medicine annual meeting in New Orleans related to the use of the bazedoxifene/conjugated estrogens complex in postmenopausal women. [click link for full article] ...
Related Topics
- Estrogen
- Data & Statistics
- Data Analysis
- Connective Tissue
- Estrogen Receptor Modulators, Selective
- National Data
- Natural therapy
- Natural therapies
- Hormone Replacement Therapy
- Color Therapy
- Music therapy
- Massage therapy
- Scars
- Pet Therapy
- Physical Therapy
- Chelation therapy
- Soft Tissue Sarcoma
- Connective Tissue Disorders
- Lamaze
- Conjugated Estrogen

Not Signed In -


